UNSPSC 51112800: Alkylating agent stilbenes

This classification denotes organic compounds that contain the functional group 1,2-diphenylethylene, substances called stilbenes, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term ALKYLATING AGENT STILBENES.

UNSPSC 51112800 Alkylating agent stilbenes is a Class code that covers pharmaceutical products used in cancer treatment and other therapeutic applications. The single recent state and local opportunity on record shows minimal alignment with the code's nominal pharmaceutical-product scope. The Texas Health and Human Services Commission issued a Request for Information (RFI) in April 2026 seeking vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, but the RFI addresses pharmacy benefit program administration, direct contracting relationships with manufacturers outside traditional pharmacy benefit manager and group purchasing organization channels, and outcomes-based pricing models rather than procurement of specific alkylating agent stilbene products themselves. The RFI explores vendor capacity to negotiate net pricing, manage volume requirements, and implement value-based agreements, but contains no product specifications, therapeutic indications, or quantities that would indicate active purchasing of the drug class under this UNSPSC code.

The code shows little relevant recent activity in state and local procurement. The Texas HHS RFI posted April 3, 2026 represents a single foundational market-intelligence exercise designed to inform future procurement strategy rather than an active solicitation for alkylating agent stilbene products. No other state or local opportunities appear in the record, no geographic spread beyond Texas is evident, and no representative product purchases under this code are documented. Absent additional solicitation activity, the code does not present a clear procurement signal for business development purposes at this time.